Utilization and Effectiveness of a Message-Based Tobacco Cessation Program (mCessation) in the Chinese General Population: Longitudinal, Real-world Study.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
02 05 2023
Historique:
received: 05 12 2022
accepted: 10 03 2023
revised: 25 02 2023
medline: 4 5 2023
pubmed: 2 5 2023
entrez: 2 5 2023
Statut: epublish

Résumé

Randomized controlled trials on text message interventions for smoking cessation have shown they are effective and recommended for tobacco control. However, the effectiveness in real-world settings is largely unknown, especially in low- and middle-income countries. This study aimed to provide real-world evidence about the utilization and effectiveness of a message-based tobacco cessation program (mCessation) in China. From May 2021 to September 2022, 16,746 people from the general population participated in the mCessation program provided by the World Health Organization. All participants received text messages on smoking cessation via instant messaging for 6 months, and they were also required to report smoking status. We randomly selected 2500 participants and interviewed them by telephone to determine the 7-day point prevalence abstinence rate at 6 months. Descriptive statistics were used to analyze population characteristics and abstinence rate. Logistic regression analysis was performed to explore risk factors for the abstinence rate. Among the 2500 participants, the mean age was 35 years, and most (2407/2500, 96.20%) were male. The prevalence of tobacco dependence and light degree of tobacco dependence were 85.70% (2142/2500) and 89.10% (2228/2500), respectively. For respondents (953/2500, 38.10%), the 7-day point prevalence abstinence rate at 6 months was 21.90% (209/953). Participants older than 40 years or with tobacco dependence had significantly higher abstinence rates than those who were younger than 30 years old (odds ratio [OR] 1.77, 95% CI 1.06-3.29) or without dependence (OR 1.64, 95% CI 1.08-2.51), respectively. However, married people or heavily dependent smokers tended to find it more difficult to successfully quit smoking compared with unmarried people (OR 0.57, 95% CI 0.34-0.93) or lightly dependent smokers (OR 0.16, 95% CI 0.02-0.98), respectively. In a real-world setting, mCessation China was generally acceptable to men and lightly dependent smokers, and it could help 1 in 5 smokers aged 18 years to 67 years quit smoking. However, strategies to increase awareness of young and married adults may improve implementation and abstinence rates.

Sections du résumé

BACKGROUND
Randomized controlled trials on text message interventions for smoking cessation have shown they are effective and recommended for tobacco control. However, the effectiveness in real-world settings is largely unknown, especially in low- and middle-income countries.
OBJECTIVE
This study aimed to provide real-world evidence about the utilization and effectiveness of a message-based tobacco cessation program (mCessation) in China.
METHODS
From May 2021 to September 2022, 16,746 people from the general population participated in the mCessation program provided by the World Health Organization. All participants received text messages on smoking cessation via instant messaging for 6 months, and they were also required to report smoking status. We randomly selected 2500 participants and interviewed them by telephone to determine the 7-day point prevalence abstinence rate at 6 months. Descriptive statistics were used to analyze population characteristics and abstinence rate. Logistic regression analysis was performed to explore risk factors for the abstinence rate.
RESULTS
Among the 2500 participants, the mean age was 35 years, and most (2407/2500, 96.20%) were male. The prevalence of tobacco dependence and light degree of tobacco dependence were 85.70% (2142/2500) and 89.10% (2228/2500), respectively. For respondents (953/2500, 38.10%), the 7-day point prevalence abstinence rate at 6 months was 21.90% (209/953). Participants older than 40 years or with tobacco dependence had significantly higher abstinence rates than those who were younger than 30 years old (odds ratio [OR] 1.77, 95% CI 1.06-3.29) or without dependence (OR 1.64, 95% CI 1.08-2.51), respectively. However, married people or heavily dependent smokers tended to find it more difficult to successfully quit smoking compared with unmarried people (OR 0.57, 95% CI 0.34-0.93) or lightly dependent smokers (OR 0.16, 95% CI 0.02-0.98), respectively.
CONCLUSIONS
In a real-world setting, mCessation China was generally acceptable to men and lightly dependent smokers, and it could help 1 in 5 smokers aged 18 years to 67 years quit smoking. However, strategies to increase awareness of young and married adults may improve implementation and abstinence rates.

Identifiants

pubmed: 37129934
pii: v25i1e44840
doi: 10.2196/44840
pmc: PMC10189622
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e44840

Informations de copyright

©Zheng Su, Xiaowen Wei, Anqi Cheng, Xinmei Zhou, Jinxuan Li, Rui Qin, Yi Liu, Xin Xia, Qingqing Song, Zhao Liu, Liang Zhao, Dan Xiao, Chen Wang. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 02.05.2023.

Références

JMIR Mhealth Uhealth. 2019 Sep 27;7(9):e12137
pubmed: 31573935
Addiction. 2022 Apr;117(4):1035-1046
pubmed: 34472676
PLoS Med. 2020 Sep 29;17(9):e1003355
pubmed: 32991589
Lancet Reg Health West Pac. 2022 May 04;24:100464
pubmed: 35538934
Clin Trials. 2006;3(6):508-12
pubmed: 17170034
Lancet. 2011 Jul 2;378(9785):49-55
pubmed: 21722952
J Bras Pneumol. 2009 Jan;35(1):73-82
pubmed: 19219334
Nicotine Tob Res. 2004 Jun;6(3):447-55
pubmed: 15203778
Lancet. 2012 Aug 18;380(9842):668-79
pubmed: 22901888
Addict Behav. 2016 Nov;62:47-53
pubmed: 27318948
J Telemed Telecare. 2013 Jul;19(5):282-7
pubmed: 24163238
Nicotine Tob Res. 2010 Oct;12 Suppl:S51-7
pubmed: 20889481
Tob Induc Dis. 2019 Apr 02;17:25
pubmed: 31582936
J Med Internet Res. 2018 Apr 19;20(4):e146
pubmed: 29674308
BMJ. 2019 May 21;365:l2204
pubmed: 31113798
Tob Induc Dis. 2019 Dec 03;17:88
pubmed: 31889950
Addiction. 2020 Oct;115(10):1902-1912
pubmed: 32149425
Nicotine Tob Res. 2021 May 24;23(6):931-938
pubmed: 32945887
JMIR Mhealth Uhealth. 2021 Oct 8;9(10):e27478
pubmed: 34623318
Lancet. 2015 Mar 14;385(9972):1019-28
pubmed: 25784349
N Engl J Med. 2010 Jun 17;362(24):2295-303
pubmed: 20554984
Lancet. 2015 Oct 10;386(10002):1447-56
pubmed: 26466050
Lancet Digit Health. 2019 Aug;1(4):e183-e192
pubmed: 33323188
JMIR Mhealth Uhealth. 2016 May 06;4(2):e59
pubmed: 27154792
JAMA Intern Med. 2016 Mar;176(3):321-8
pubmed: 26903176
PLoS Med. 2018 Dec 18;15(12):e1002713
pubmed: 30562352

Auteurs

Zheng Su (Z)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Xiaowen Wei (X)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Capital Medical University, China-Japan Friendship School of Clinical Medicine, Beijing, China.

Anqi Cheng (A)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Xinmei Zhou (X)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Jinxuan Li (J)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Capital Medical University, China-Japan Friendship School of Clinical Medicine, Beijing, China.

Rui Qin (R)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Yi Liu (Y)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Xin Xia (X)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Qingqing Song (Q)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Capital Medical University, China-Japan Friendship School of Clinical Medicine, Beijing, China.

Zhao Liu (Z)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Liang Zhao (L)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Dan Xiao (D)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Chen Wang (C)

Department of Tobacco Control and Prevention of Respiratory Diseases, China-Japan Friendship Hospital, Center of Respiratory Medicine, Beijing, China.
World Health Organization Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
National Clinical Research Center for Respiratory Diseases, Beijing, China.
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
National Center for Respiratory Medicine, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH